The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Long-acting Antipsychotic Market Research Report 2025

Global Long-acting Antipsychotic Market Research Report 2025

Publishing Date : Mar, 2025

License Type :

Report Code : 1983747

No of Pages : 93

Ask Your Query

Report Description
Table of Content

Synopsis
The global Long-acting Antipsychotic market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Long-acting Antipsychotic is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Long-acting Antipsychotic is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Long-acting Antipsychotic include Oakwood Labs, Teva, MedinCell, Janssen, Otsuka America Pharmaceutical, Inc., Lundbeck, Eli Lilly, Alkermes, Par Pharmaceutical, AbbVie, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Long-acting Antipsychotic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Long-acting Antipsychotic.
The Long-acting Antipsychotic market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Long-acting Antipsychotic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Long-acting Antipsychotic manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Oakwood Labs
Teva
MedinCell
Janssen
Otsuka America Pharmaceutical, Inc.
Lundbeck
Eli Lilly
Alkermes
Par Pharmaceutical
AbbVie
Luye Pharmaceutical
Segment by Type
Aripiprazole
Haloperidol
Paliperidone
Risperidone
Olanzapine
Others
Segment by Application
Schizophrenia
Bipolar Disorder
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Long-acting Antipsychotic manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Long-acting Antipsychotic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Long-acting Antipsychotic Market Overview
1.1 Product Definition
1.2 Long-acting Antipsychotic by Type
1.2.1 Global Long-acting Antipsychotic Market Value Comparison by Type (2024-2030)
1.2.2 Aripiprazole
1.2.3 Haloperidol
1.2.4 Paliperidone
1.2.5 Risperidone
1.2.6 Olanzapine
1.2.7 Others
1.3 Long-acting Antipsychotic by Application
1.3.1 Global Long-acting Antipsychotic Market Value by Application (2024-2030)
1.3.2 Schizophrenia
1.3.3 Bipolar Disorder
1.3.4 Others
1.4 Global Long-acting Antipsychotic Market Size Estimates and Forecasts
1.4.1 Global Long-acting Antipsychotic Revenue 2019-2030
1.4.2 Global Long-acting Antipsychotic Sales 2019-2030
1.4.3 Global Long-acting Antipsychotic Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Long-acting Antipsychotic Market Competition by Manufacturers
2.1 Global Long-acting Antipsychotic Sales Market Share by Manufacturers (2019-2024)
2.2 Global Long-acting Antipsychotic Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Long-acting Antipsychotic Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Long-acting Antipsychotic, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Long-acting Antipsychotic, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Long-acting Antipsychotic, Product Type & Application
2.7 Global Key Manufacturers of Long-acting Antipsychotic, Date of Enter into This Industry
2.8 Global Long-acting Antipsychotic Market Competitive Situation and Trends
2.8.1 Global Long-acting Antipsychotic Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Long-acting Antipsychotic Players Market Share by Revenue
2.8.3 Global Long-acting Antipsychotic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Long-acting Antipsychotic Market Scenario by Region
3.1 Global Long-acting Antipsychotic Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Long-acting Antipsychotic Sales by Region: 2019-2030
3.2.1 Global Long-acting Antipsychotic Sales by Region: 2019-2024
3.2.2 Global Long-acting Antipsychotic Sales by Region: 2025-2030
3.3 Global Long-acting Antipsychotic Revenue by Region: 2019-2030
3.3.1 Global Long-acting Antipsychotic Revenue by Region: 2019-2024
3.3.2 Global Long-acting Antipsychotic Revenue by Region: 2025-2030
3.4 North America Long-acting Antipsychotic Market Facts & Figures by Country
3.4.1 North America Long-acting Antipsychotic Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Long-acting Antipsychotic Sales by Country (2019-2030)
3.4.3 North America Long-acting Antipsychotic Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Long-acting Antipsychotic Market Facts & Figures by Country
3.5.1 Europe Long-acting Antipsychotic Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Long-acting Antipsychotic Sales by Country (2019-2030)
3.5.3 Europe Long-acting Antipsychotic Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Long-acting Antipsychotic Market Facts & Figures by Region
3.6.1 Asia Pacific Long-acting Antipsychotic Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Long-acting Antipsychotic Sales by Region (2019-2030)
3.6.3 Asia Pacific Long-acting Antipsychotic Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Long-acting Antipsychotic Market Facts & Figures by Country
3.7.1 Latin America Long-acting Antipsychotic Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Long-acting Antipsychotic Sales by Country (2019-2030)
3.7.3 Latin America Long-acting Antipsychotic Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Long-acting Antipsychotic Market Facts & Figures by Country
3.8.1 Middle East and Africa Long-acting Antipsychotic Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Long-acting Antipsychotic Sales by Country (2019-2030)
3.8.3 Middle East and Africa Long-acting Antipsychotic Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Long-acting Antipsychotic Sales by Type (2019-2030)
4.1.1 Global Long-acting Antipsychotic Sales by Type (2019-2024)
4.1.2 Global Long-acting Antipsychotic Sales by Type (2025-2030)
4.1.3 Global Long-acting Antipsychotic Sales Market Share by Type (2019-2030)
4.2 Global Long-acting Antipsychotic Revenue by Type (2019-2030)
4.2.1 Global Long-acting Antipsychotic Revenue by Type (2019-2024)
4.2.2 Global Long-acting Antipsychotic Revenue by Type (2025-2030)
4.2.3 Global Long-acting Antipsychotic Revenue Market Share by Type (2019-2030)
4.3 Global Long-acting Antipsychotic Price by Type (2019-2030)
5 Segment by Application
5.1 Global Long-acting Antipsychotic Sales by Application (2019-2030)
5.1.1 Global Long-acting Antipsychotic Sales by Application (2019-2024)
5.1.2 Global Long-acting Antipsychotic Sales by Application (2025-2030)
5.1.3 Global Long-acting Antipsychotic Sales Market Share by Application (2019-2030)
5.2 Global Long-acting Antipsychotic Revenue by Application (2019-2030)
5.2.1 Global Long-acting Antipsychotic Revenue by Application (2019-2024)
5.2.2 Global Long-acting Antipsychotic Revenue by Application (2025-2030)
5.2.3 Global Long-acting Antipsychotic Revenue Market Share by Application (2019-2030)
5.3 Global Long-acting Antipsychotic Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Oakwood Labs
6.1.1 Oakwood Labs Company Information
6.1.2 Oakwood Labs Description and Business Overview
6.1.3 Oakwood Labs Long-acting Antipsychotic Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Oakwood Labs Long-acting Antipsychotic Product Portfolio
6.1.5 Oakwood Labs Recent Developments/Updates
6.2 Teva
6.2.1 Teva Company Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Long-acting Antipsychotic Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Teva Long-acting Antipsychotic Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 MedinCell
6.3.1 MedinCell Company Information
6.3.2 MedinCell Description and Business Overview
6.3.3 MedinCell Long-acting Antipsychotic Sales, Revenue and Gross Margin (2019-2024)
6.3.4 MedinCell Long-acting Antipsychotic Product Portfolio
6.3.5 MedinCell Recent Developments/Updates
6.4 Janssen
6.4.1 Janssen Company Information
6.4.2 Janssen Description and Business Overview
6.4.3 Janssen Long-acting Antipsychotic Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Janssen Long-acting Antipsychotic Product Portfolio
6.4.5 Janssen Recent Developments/Updates
6.5 Otsuka America Pharmaceutical, Inc.
6.5.1 Otsuka America Pharmaceutical, Inc. Company Information
6.5.2 Otsuka America Pharmaceutical, Inc. Description and Business Overview
6.5.3 Otsuka America Pharmaceutical, Inc. Long-acting Antipsychotic Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Otsuka America Pharmaceutical, Inc. Long-acting Antipsychotic Product Portfolio
6.5.5 Otsuka America Pharmaceutical, Inc. Recent Developments/Updates
6.6 Lundbeck
6.6.1 Lundbeck Company Information
6.6.2 Lundbeck Description and Business Overview
6.6.3 Lundbeck Long-acting Antipsychotic Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Lundbeck Long-acting Antipsychotic Product Portfolio
6.6.5 Lundbeck Recent Developments/Updates
6.7 Eli Lilly
6.7.1 Eli Lilly Company Information
6.7.2 Eli Lilly Description and Business Overview
6.7.3 Eli Lilly Long-acting Antipsychotic Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Eli Lilly Long-acting Antipsychotic Product Portfolio
6.7.5 Eli Lilly Recent Developments/Updates
6.8 Alkermes
6.8.1 Alkermes Company Information
6.8.2 Alkermes Description and Business Overview
6.8.3 Alkermes Long-acting Antipsychotic Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Alkermes Long-acting Antipsychotic Product Portfolio
6.8.5 Alkermes Recent Developments/Updates
6.9 Par Pharmaceutical
6.9.1 Par Pharmaceutical Company Information
6.9.2 Par Pharmaceutical Description and Business Overview
6.9.3 Par Pharmaceutical Long-acting Antipsychotic Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Par Pharmaceutical Long-acting Antipsychotic Product Portfolio
6.9.5 Par Pharmaceutical Recent Developments/Updates
6.10 AbbVie
6.10.1 AbbVie Company Information
6.10.2 AbbVie Description and Business Overview
6.10.3 AbbVie Long-acting Antipsychotic Sales, Revenue and Gross Margin (2019-2024)
6.10.4 AbbVie Long-acting Antipsychotic Product Portfolio
6.10.5 AbbVie Recent Developments/Updates
6.11 Luye Pharmaceutical
6.11.1 Luye Pharmaceutical Company Information
6.11.2 Luye Pharmaceutical Description and Business Overview
6.11.3 Luye Pharmaceutical Long-acting Antipsychotic Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Luye Pharmaceutical Long-acting Antipsychotic Product Portfolio
6.11.5 Luye Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Long-acting Antipsychotic Industry Chain Analysis
7.2 Long-acting Antipsychotic Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Long-acting Antipsychotic Production Mode & Process
7.4 Long-acting Antipsychotic Sales and Marketing
7.4.1 Long-acting Antipsychotic Sales Channels
7.4.2 Long-acting Antipsychotic Distributors
7.5 Long-acting Antipsychotic Customers
8 Long-acting Antipsychotic Market Dynamics
8.1 Long-acting Antipsychotic Industry Trends
8.2 Long-acting Antipsychotic Market Drivers
8.3 Long-acting Antipsychotic Market Challenges
8.4 Long-acting Antipsychotic Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Long-acting Antipsychotic Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Long-acting Antipsychotic Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Long-acting Antipsychotic Market Competitive Situation by Manufacturers in 2023
Table 4. Global Long-acting Antipsychotic Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Long-acting Antipsychotic Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Long-acting Antipsychotic Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Long-acting Antipsychotic Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Long-acting Antipsychotic Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Long-acting Antipsychotic, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Long-acting Antipsychotic, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Long-acting Antipsychotic, Product Type & Application
Table 12. Global Key Manufacturers of Long-acting Antipsychotic, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Long-acting Antipsychotic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-acting Antipsychotic as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Long-acting Antipsychotic Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Long-acting Antipsychotic Sales by Region (2019-2024) & (K Units)
Table 18. Global Long-acting Antipsychotic Sales Market Share by Region (2019-2024)
Table 19. Global Long-acting Antipsychotic Sales by Region (2025-2030) & (K Units)
Table 20. Global Long-acting Antipsychotic Sales Market Share by Region (2025-2030)
Table 21. Global Long-acting Antipsychotic Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Long-acting Antipsychotic Revenue Market Share by Region (2019-2024)
Table 23. Global Long-acting Antipsychotic Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Long-acting Antipsychotic Revenue Market Share by Region (2025-2030)
Table 25. North America Long-acting Antipsychotic Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Long-acting Antipsychotic Sales by Country (2019-2024) & (K Units)
Table 27. North America Long-acting Antipsychotic Sales by Country (2025-2030) & (K Units)
Table 28. North America Long-acting Antipsychotic Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Long-acting Antipsychotic Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Long-acting Antipsychotic Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Long-acting Antipsychotic Sales by Country (2019-2024) & (K Units)
Table 32. Europe Long-acting Antipsychotic Sales by Country (2025-2030) & (K Units)
Table 33. Europe Long-acting Antipsychotic Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Long-acting Antipsychotic Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Long-acting Antipsychotic Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Long-acting Antipsychotic Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Long-acting Antipsychotic Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Long-acting Antipsychotic Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Long-acting Antipsychotic Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Long-acting Antipsychotic Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Long-acting Antipsychotic Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Long-acting Antipsychotic Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Long-acting Antipsychotic Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Long-acting Antipsychotic Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Long-acting Antipsychotic Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Long-acting Antipsychotic Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Long-acting Antipsychotic Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Long-acting Antipsychotic Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Long-acting Antipsychotic Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Long-acting Antipsychotic Sales (K Units) by Type (2019-2024)
Table 51. Global Long-acting Antipsychotic Sales (K Units) by Type (2025-2030)
Table 52. Global Long-acting Antipsychotic Sales Market Share by Type (2019-2024)
Table 53. Global Long-acting Antipsychotic Sales Market Share by Type (2025-2030)
Table 54. Global Long-acting Antipsychotic Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Long-acting Antipsychotic Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Long-acting Antipsychotic Revenue Market Share by Type (2019-2024)
Table 57. Global Long-acting Antipsychotic Revenue Market Share by Type (2025-2030)
Table 58. Global Long-acting Antipsychotic Price (US$/Unit) by Type (2019-2024)
Table 59. Global Long-acting Antipsychotic Price (US$/Unit) by Type (2025-2030)
Table 60. Global Long-acting Antipsychotic Sales (K Units) by Application (2019-2024)
Table 61. Global Long-acting Antipsychotic Sales (K Units) by Application (2025-2030)
Table 62. Global Long-acting Antipsychotic Sales Market Share by Application (2019-2024)
Table 63. Global Long-acting Antipsychotic Sales Market Share by Application (2025-2030)
Table 64. Global Long-acting Antipsychotic Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Long-acting Antipsychotic Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Long-acting Antipsychotic Revenue Market Share by Application (2019-2024)
Table 67. Global Long-acting Antipsychotic Revenue Market Share by Application (2025-2030)
Table 68. Global Long-acting Antipsychotic Price (US$/Unit) by Application (2019-2024)
Table 69. Global Long-acting Antipsychotic Price (US$/Unit) by Application (2025-2030)
Table 70. Oakwood Labs Company Information
Table 71. Oakwood Labs Description and Business Overview
Table 72. Oakwood Labs Long-acting Antipsychotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Oakwood Labs Long-acting Antipsychotic Product
Table 74. Oakwood Labs Recent Developments/Updates
Table 75. Teva Company Information
Table 76. Teva Description and Business Overview
Table 77. Teva Long-acting Antipsychotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Teva Long-acting Antipsychotic Product
Table 79. Teva Recent Developments/Updates
Table 80. MedinCell Company Information
Table 81. MedinCell Description and Business Overview
Table 82. MedinCell Long-acting Antipsychotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. MedinCell Long-acting Antipsychotic Product
Table 84. MedinCell Recent Developments/Updates
Table 85. Janssen Company Information
Table 86. Janssen Description and Business Overview
Table 87. Janssen Long-acting Antipsychotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Janssen Long-acting Antipsychotic Product
Table 89. Janssen Recent Developments/Updates
Table 90. Otsuka America Pharmaceutical, Inc. Company Information
Table 91. Otsuka America Pharmaceutical, Inc. Description and Business Overview
Table 92. Otsuka America Pharmaceutical, Inc. Long-acting Antipsychotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Otsuka America Pharmaceutical, Inc. Long-acting Antipsychotic Product
Table 94. Otsuka America Pharmaceutical, Inc. Recent Developments/Updates
Table 95. Lundbeck Company Information
Table 96. Lundbeck Description and Business Overview
Table 97. Lundbeck Long-acting Antipsychotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Lundbeck Long-acting Antipsychotic Product
Table 99. Lundbeck Recent Developments/Updates
Table 100. Eli Lilly Company Information
Table 101. Eli Lilly Description and Business Overview
Table 102. Eli Lilly Long-acting Antipsychotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Eli Lilly Long-acting Antipsychotic Product
Table 104. Eli Lilly Recent Developments/Updates
Table 105. Alkermes Company Information
Table 106. Alkermes Description and Business Overview
Table 107. Alkermes Long-acting Antipsychotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Alkermes Long-acting Antipsychotic Product
Table 109. Alkermes Recent Developments/Updates
Table 110. Par Pharmaceutical Company Information
Table 111. Par Pharmaceutical Description and Business Overview
Table 112. Par Pharmaceutical Long-acting Antipsychotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Par Pharmaceutical Long-acting Antipsychotic Product
Table 114. Par Pharmaceutical Recent Developments/Updates
Table 115. AbbVie Company Information
Table 116. AbbVie Description and Business Overview
Table 117. AbbVie Long-acting Antipsychotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. AbbVie Long-acting Antipsychotic Product
Table 119. AbbVie Recent Developments/Updates
Table 120. Luye Pharmaceutical Company Information
Table 121. Luye Pharmaceutical Description and Business Overview
Table 122. Luye Pharmaceutical Long-acting Antipsychotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Luye Pharmaceutical Long-acting Antipsychotic Product
Table 124. Luye Pharmaceutical Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Long-acting Antipsychotic Distributors List
Table 128. Long-acting Antipsychotic Customers List
Table 129. Long-acting Antipsychotic Market Trends
Table 130. Long-acting Antipsychotic Market Drivers
Table 131. Long-acting Antipsychotic Market Challenges
Table 132. Long-acting Antipsychotic Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report

List of Figures
Figure 1. Product Picture of Long-acting Antipsychotic
Figure 2. Global Long-acting Antipsychotic Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Long-acting Antipsychotic Market Share by Type: 2023 & 2030
Figure 4. Aripiprazole Product Picture
Figure 5. Haloperidol Product Picture
Figure 6. Paliperidone Product Picture
Figure 7. Risperidone Product Picture
Figure 8. Olanzapine Product Picture
Figure 9. Others Product Picture
Figure 10. Global Long-acting Antipsychotic Market Value by Application (2024-2030) & (US$ Million)
Figure 11. Global Long-acting Antipsychotic Market Share by Application: 2023 & 2030
Figure 12. Schizophrenia
Figure 13. Bipolar Disorder
Figure 14. Others
Figure 15. Global Long-acting Antipsychotic Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Long-acting Antipsychotic Market Size (2019-2030) & (US$ Million)
Figure 17. Global Long-acting Antipsychotic Sales (2019-2030) & (K Units)
Figure 18. Global Long-acting Antipsychotic Average Price (US$/Unit) & (2019-2030)
Figure 19. Long-acting Antipsychotic Report Years Considered
Figure 20. Long-acting Antipsychotic Sales Share by Manufacturers in 2023
Figure 21. Global Long-acting Antipsychotic Revenue Share by Manufacturers in 2023
Figure 22. Global 5 and 10 Largest Long-acting Antipsychotic Players: Market Share by Revenue in Long-acting Antipsychotic in 2023
Figure 23. Long-acting Antipsychotic Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 24. Global Long-acting Antipsychotic Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 25. North America Long-acting Antipsychotic Sales Market Share by Country (2019-2030)
Figure 26. North America Long-acting Antipsychotic Revenue Market Share by Country (2019-2030)
Figure 27. United States Long-acting Antipsychotic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Canada Long-acting Antipsychotic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Europe Long-acting Antipsychotic Sales Market Share by Country (2019-2030)
Figure 30. Europe Long-acting Antipsychotic Revenue Market Share by Country (2019-2030)
Figure 31. Germany Long-acting Antipsychotic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. France Long-acting Antipsychotic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. U.K. Long-acting Antipsychotic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Italy Long-acting Antipsychotic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Russia Long-acting Antipsychotic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Asia Pacific Long-acting Antipsychotic Sales Market Share by Region (2019-2030)
Figure 37. Asia Pacific Long-acting Antipsychotic Revenue Market Share by Region (2019-2030)
Figure 38. China Long-acting Antipsychotic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Japan Long-acting Antipsychotic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. South Korea Long-acting Antipsychotic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. India Long-acting Antipsychotic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Australia Long-acting Antipsychotic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. China Taiwan Long-acting Antipsychotic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Long-acting Antipsychotic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Long-acting Antipsychotic Sales Market Share by Country (2019-2030)
Figure 46. Mexico Long-acting Antipsychotic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Long-acting Antipsychotic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Long-acting Antipsychotic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Colombia Long-acting Antipsychotic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East and Africa Long-acting Antipsychotic Sales Market Share by Country (2019-2030)
Figure 51. Middle East and Africa Long-acting Antipsychotic Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Long-acting Antipsychotic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Long-acting Antipsychotic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Long-acting Antipsychotic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Long-acting Antipsychotic by Type (2019-2030)
Figure 56. Global Revenue Market Share of Long-acting Antipsychotic by Type (2019-2030)
Figure 57. Global Long-acting Antipsychotic Price (US$/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Long-acting Antipsychotic by Application (2019-2030)
Figure 59. Global Revenue Market Share of Long-acting Antipsychotic by Application (2019-2030)
Figure 60. Global Long-acting Antipsychotic Price (US$/Unit) by Application (2019-2030)
Figure 61. Long-acting Antipsychotic Value Chain
Figure 62. Long-acting Antipsychotic Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business:

Since 2015

Pre Sales Support:

24*7

Post Sales Support:

24*7

Turn Around Time:

Usually 2 Hours

Clients Served:

425 and counting

Clients Assisted:

1750 and counting

Client Types:

Govt Projects, Private Companies, Consultant and Individuals

Payment:

Partners with:

Number of reports:

1,000,000 and counting

Custom Research:

Available

Report Availability:

Global and Regional Reports

Report Delivery Format:

Usually PDF

Security:

Latest Life Science Market Reports

Global Support Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Hospital OT and X-Ray, Cathode Room Doors (Hermetically Sealed Door) Market Research Report 2025

Global Children\'s DHA Market Research Report 2025

Global Marine Derived Drugs Market Research Report 2025

Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Payments Accepted From

Connect with us at

Complete Secure Website

#socialicons>a span { top: 0px; left: -100%; -webkit-transition: all 0.3s ease; -moz-transition: all 0.3s ease-in-out; -o-transition: all 0.3s ease-in-out; -ms-transition: all 0.3s ease-in-out; transition: all 0.3s ease-in-out;} #socialicons>ahover div{left: 0px;}